Literature DB >> 12713870

The mitogenic activity of the liver growth factor is mediated by tumor necrosis factor alpha in rat liver.

Juan J Díaz-Gil1, Pedro L Majano, Manuel López-Cabrera, Vicente Sánchez-López, Carmen Rúa, Celia Machín, Carolina Trilla, Rafael García-Cañero, Ricardo Moreno-Otero.   

Abstract

BACKGROUND/AIMS: Liver growth factor (LGF) is a hepatic mitogen, however, the hepatic stimulation pathway remains to be characterized. The aim of this study was to determine whether tumor necrosis factor alpha (TNF-alpha) stimulation constitutes a step in the mitogenic pathway of LGF.
METHODS: Rats were injected with 4.5 microg LGF/rat, and LGF activity was measured both by liver DNA synthesis stimulation and "proliferating cell nuclear antigen (PCNA)-positive" hepatocytes in rats injected with LGF or +anti-TNF-alpha. TNF-alpha expression was evaluated by reverse-transcription polymerase chain reaction. TNF-alpha-producing cells were immunodetected. Human endothelial cells (HUVEC) were stimulated by LGF. TNF-alpha was detected in the supernatant, and the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular endothelial adhesion molecule-1 (VCAM-1) by flow cytometry analysis.
RESULTS: LGF-injected rats showed higher intrahepatic TNF-alpha expression. DNA synthesis and PCNA-positive hepatocytes induced by LGF were inhibited by anti-TNF-alpha, PCNA-positive hepatocytes being especially abundant around the central vein when LGF was injected alone, but TNF-alpha exhibited increased signal intensity in endothelial cells of the portal vein. LGF stimulated TNF-alpha secretion in HUVEC, but did not stimulate ICAM-1 or VCAM-1 up-regulation.
CONCLUSIONS: The mitogenic cascade initiated by LGF in rat liver in vivo depends, at least in part, on TNF-alpha stimulation. Portal vein endothelial cells seem to be a source of TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713870     DOI: 10.1016/s0168-8278(03)00030-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor.

Authors:  Rafael Gonzalo-Gobernado; Diana Reimers; Antonio S Herranz; Juan José Díaz-Gil; Cristina Osuna; María José Asensio; Silvia Baena; Macarena Rodríguez-Serrano; Eulalia Bazán
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

Review 2.  Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

Review 3.  Liver growth factor as a tissue regenerating factor in neurodegenerative diseases.

Authors:  Rafael Gonzalo-Gobernado; Lucia Calatrava-Ferreras; Juan Perucho; Diana Reimers; MarIa J Casarejos; Antonio S Herranz; Adriano Jimenez-Escrig; Juan J Diaz-Gil; Eulalia Bazan
Journal:  Recent Pat CNS Drug Discov       Date:  2014

4.  Proliferative activity of liver growth factor is associated with an improvement of cigarette smoke-induced emphysema in mice.

Authors:  Álvaro Girón-Martínez; Sandra Pérez-Rial; Raúl Terrón-Expósito; Juan José Díaz-Gil; Nicolás González-Mangado; Germán Peces-Barba
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease.

Authors:  Rafael Gonzalo-Gobernado; Diana Reimers; María José Casarejos; Lucía Calatrava Ferreras; Manuela Vallejo-Muñoz; Adriano Jiménez-Escrig; Juan José Diaz-Gil; Gonzalo M Ulzurrun de Asanza; Eulalia Bazán
Journal:  Brain Sci       Date:  2020-05-22

6.  Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.

Authors:  Gayathri Balandaram; Lance R Kramer; Boo-Hyon Kang; Iain A Murray; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2016-07-15       Impact factor: 4.571

7.  Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.

Authors:  Rafael Gonzalo-Gobernado; Lucía Calatrava-Ferreras; Diana Reimers; Antonio Sánchez Herranz; Macarena Rodríguez-Serrano; Cristina Miranda; Adriano Jiménez-Escrig; Juan José Díaz-Gil; Eulalia Bazán
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.